Company news

AdAlta Ltd. news in 2021

AdAlta Ltd.'s news releases, calls and decks from 2021, newest first.

View company

Entitlement Offer Booklet

December 22, 2021

Reinstatement to Quotation

December 14, 2021

Voluntary Suspension

December 13, 2021

Inhaled AD-214 passes first development milestone

December 8, 2021

AGM presentations & first iCAR-T data

November 28, 2021

Second US patent for AD-214

November 17, 2021

BTB funding transferred to AD-214 inhalation program

October 6, 2021

New pre-clinical data presented at Boston conference

September 26, 2021

Corporate overview and IRD Invest 2021 presentation

September 20, 2021

$4.0M Non-Dilutive Financing with Victorian Government

September 19, 2021

Carina collaboration webinar presentation

August 25, 2021

CAR-T collaboration with Carina Biotech

August 23, 2021

Webinar and presentation on AD-214 strategy

July 19, 2021

AD-214 pathway to IPF efficacy studies

July 18, 2021

AdAlta secures AD-214 resupply

July 1, 2021

R&D Tax Incentive Facility

June 24, 2021

GE Healthcare collaboration advances to next stage

May 23, 2021

AdAlta granted Japanese patent for AD-214

May 18, 2021

Mutiple Dose Part Of Ad-214 Phase I Trial Commenced

April 18, 2021

Investor briefing-AD-214 top line single dose safety results

March 9, 2021

Appendix 4D and Interim Financial Report

February 25, 2021

FDA Orphan Drug Designation for AD-214

February 23, 2021

Decks in 2021